Literature DB >> 29756113

Primary splenic angiosarcoma diagnosed after splenectomy for spontaneous rupture.

Barış Özcan1, Metin Çevener2, Ayşegül Odabaşı Kargı3, Hilmi Dikici4, Akın Yıldız5, Mustafa Özdoğan3, Alihan Gürkan6.   

Abstract

Primary splenic angiosarcoma is a rare abnormality and has a bad prognosis. It has unknown pathogenesis. This abnormality is usually presented by splenic rupture. Surgery is the most promising treatm Surgery is the most accepted and accurate method for diagnosis and treatment. Surgery before rupture increases the life expectancy. A 65-year-old woman who presented to the emergency room with abdominal pain, abdominal distension, and anemia was found to have a splenic mass and massive ascites. After getting a hemorrhagic sample from the abdomen, the patient was operated with splenic rupture prediagnosis. The spleen material was reported as splenic angiosarcoma. The staging 18F-FDG-Positron Emission Tomography-Computed Tomography did not show any metastasis. Five months later, paclitaxel treatment was initiated upon liver and bone metastasis, and the treatment still continues. Splenic angiosarcoma has a place among splenic parenchymal lesions. The splenectomy material names the diagnosis. Pathologic examination of splenectomy material is revealed certain diagnosis.

Entities:  

Keywords:  Imaging; primary splenic angiosarcoma; splenectomy; spontaneous splenic rupture

Year:  2018        PMID: 29756113      PMCID: PMC5937666          DOI: 10.5152/turkjsurg.2017.3207

Source DB:  PubMed          Journal:  Turk J Surg        ISSN: 2564-6850


  9 in total

1.  Thrombocytopenia as first manifestation of splenic angiosarcoma.

Authors:  Simon Raffel; Bert Hildebrandt; Christian Grieser; Stefan Pahl; Isrid Sturm
Journal:  Ann Hematol       Date:  2009-07-01       Impact factor: 3.673

2.  CT findings in primary vascular tumors of the spleen.

Authors:  F Ferrozzi; D Bova; F Draghi; G Garlaschi
Journal:  AJR Am J Roentgenol       Date:  1996-05       Impact factor: 3.959

3.  Ruptured primary splenic angiosarcoma into the colon. Presentation as anal bleeding.

Authors:  J A Jiménez-Heffernan; D Hardisson; M I Prieto-Nieto; E Burgos
Journal:  Acta Gastroenterol Belg       Date:  1999 Apr-Jun       Impact factor: 1.316

4.  Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.

Authors:  Antoine Italiano; Angela Cioffi; Nicolas Penel; Matteo Giaj Levra; Corinne Delcambre; Elsa Kalbacher; Christine Chevreau; François Bertucci; Nicolas Isambert; Jean-Yves Blay; Binh Bui; Cristina Antonescu; David R D'Adamo; Robert G Maki; Mary Louise Keohan
Journal:  Cancer       Date:  2011-11-01       Impact factor: 6.860

5.  Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases.

Authors:  T S Neuhauser; G A Derringer; L D Thompson; J C Fanburg-Smith; M Miettinen; A Saaristo; S L Abbondanzo
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

6.  Angiosarcoma of the spleen: imaging characteristics in 12 patients.

Authors:  William M Thompson; Angela D Levy; Nadine S Aguilera; Luis Gorospe; Robert M Abbott
Journal:  Radiology       Date:  2005-03-04       Impact factor: 11.105

7.  Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases.

Authors:  S Falk; J Krishnan; J M Meis
Journal:  Am J Surg Pathol       Date:  1993-10       Impact factor: 6.394

8.  Systemic therapy in primary angiosarcoma of the spleen.

Authors:  Bruna Pellini Ferreira; Eve T Rodler; Elizabeth T Loggers; Seth M Pollack; Robin L Jones
Journal:  Rare Tumors       Date:  2012-11-13

Review 9.  Spontaneous rupture of primary splenic angiosarcoma: a case report and literature review.

Authors:  Yun-Fei Duan; Yong Jiang; Chuan-Xing Wu; Feng Zhu
Journal:  World J Surg Oncol       Date:  2013-03-04       Impact factor: 2.754

  9 in total
  1 in total

1.  Relapsing Haemothorax as an Unusual Presentation of Primary Angiosarcoma of the Spleen.

Authors:  Alba Bergas; Francesc Escrihuela-Vidal; Davinia Fernández Calvo; Olga Capdevila Pons; Xavier Corbella
Journal:  Eur J Case Rep Intern Med       Date:  2020-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.